Atossa Genetics (ATOS) Misses Q2 EPS by 1c

Atossa Genetics (NASDAQ: ATOS) reported Q2 EPS of ($0.07), $0.01 worse than the analyst estimate of ($0.06).

For earnings history and earnings-related data on Atossa Genetics (ATOS) click here.

You May Also Be Interested In

• Baird on Nurix (NRIX) Earnings Amid 7% Drop: '2Q Print Solid as Breadth of Development Expands'
• Raymond James Previews Charles Schwab Corp. (SCHW) Earnings: 'Elevated Trading Volumes Drives Trading Revenue Upside'
• Active options: MSTR SPCX IREN AMD HOOD ORCL GOOGL MARA SMCI